Medical Marijuana Market , By Application (Pain Management, Muscle spasms, Nausea, Anorexia, Seizures, Others), By Route of Administration (Inhalation, Oral Topical), By Distribution Channel (Dispensaries, Online), Regional Analysis (North America, Europe, Asia Pacific, LAMEA) Global Opportunity Analysis and Industry Forecast, 2019–2026
- RES4072084
- 135 Pages
- February 2020
- Healthcare
Medical Marijuana Market Analysis:
Aging population across the developed & developing countries along with commercialization of cannabis-based therapeutic drugs is projected to spur the medical marijuana market growth. Rising cancer burden along with rising demand for chronic pain management & treatment is also expected to boost the medical marijuana market. Moreover, factor such as R&D activities, clinical trials along with legalization of marijuana are anticipated to boost the global market. additionally, rising disposable incomes in the emerging economies is projected to create a major impact on medical marijuana market. However, strict government regulation and lack of safety information shall hamper the growth of global market.
People's Republic of China (PRC) is mainly involved in the clinical research along with it China has large production of cannabis. In addition, market players such as Hanma Investment Group initiated extract CBD (Cannabidiol) in PRC. This company exports 90% of its production to European as well as Asian countries. Aforementioned, factors expected to create enormous opportunities for the medical marijuana market.
On the basis of application, medical marijuana market is segmented into Pain management, nausea, muscle spasms, anorexia, seizures and others. Pain management segment generated a revenue of $2,068.3 million in 2018, and is projected to surpass $15,133.9 million by 2026.
On the basis of route of administration, medical marijuana market is majorly segmented into inhalation topical and oral. Inhalation segment registered a revenue of $3,463.2 million in 2018, and is anticipated to cross $25,162.8 million, during the forecasted period.
On the basis of distribution channel, medical marijuana market is majorly segmented into Dispensaries and online. Dispensaries segment generated a revenue of $3,795.1 million in 2018, and is projected to surpass $26,647.2 million by 2026. Online segment generated revenue of $1,014.9 million in 2018, and is further estimated to reach upto $9,58.2 million, throughout the forecasted period.
Based on the geographical region, medical marijuana market is categorized into North America, Asia Pacific, Europe & LAMEA. Asia-Pacific Medical Marijuana Market size shall cross $8,037.6 million by 2026. North America has significant share in medical marijuana market, during the forecasted period. North America medical marijuana market registered $1,726.8 million in 2018, and is anticipated to cross $11,404.7 during the projected period.
Some of the major players of Medical Marijuana Market include ABcann Medicinals, Inc., Aurora Cannabis, Inc., Aphria, Inc., Canopy Growth Corporation, Cannabis Sativa Inc., Emerald Health Therapeutics, Green Relief Inc., GW Pharmaceuticals, Insys Therapeutics, Inc., mCig to gain competitive advantage, these companies investing in huge amount on the research and development activities to improve cannabis based therapeutic drugs.
1.1. Desk Research
1.2. Real time insights and validation
1.3. Forecast model
1.4. Assumptions and forecast parameters
1.4.1. Assumptions
1.4.2. Forecast parameters
1.5. Data sources
1.5.1. Primary
1.5.2. Secondary
2. Executive Summary
2.1. 360° summary
2.2. Application
2.3. Route of Administration
2.4. Distribution Channel
3. Market overview
3.1. Market segmentation & definitions
3.2. Key takeaways
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Porter’s five forces analysis
3.3.1. Bargaining power of consumers
3.3.2. Bargaining power of suppliers
3.3.3. Threat of new entrants
3.3.4. Threat of substitutes
3.3.5. Competitive rivalry in the market
3.4. Market dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
3.5. Technology landscape
3.6. Regulatory landscape
3.7. Patent landscape
3.8. Market value chain analysis
3.8.1. Stress point analysis
3.9. Strategic overview
4. Medical Marijuana Market, by Application
4.1. Pain Management
4.1.1. Market size and forecast, by region, 2018-2026
4.1.2. Comparative market share analysis, 2018 & 2026
4.2. Muscle spasms
4.2.1. Market size and forecast, by region, 2018-2026
4.2.2. Comparative market share analysis, 2018 & 2026
4.3. Nausea
4.3.1. Market size and forecast, by region, 2018-2026
4.3.2. Comparative market share analysis, 2018 & 2026
4.4. Anorexia
4.4.1. Market size and forecast, by region, 2018-2026
4.4.2. Comparative market share analysis, 2018 & 2026
4.5. Seizures
4.5.1. Market size and forecast, by region, 2018-2026
4.5.2. Comparative market share analysis, 2018 & 2026
4.6. Others
4.6.1. Market size and forecast, by region, 2018-2026
4.6.2. Comparative market share analysis, 2018 & 2026
5. Medical Marijuana Market, by Route of Administration
5.1. Inhalation
5.1.1. Market size and forecast, by region, 2018-2026
5.1.2. Comparative market share analysis, 2018 & 2026
5.2. Oral
5.2.1. Market size and forecast, by region, 2018-2026
5.2.2. Comparative market share analysis, 2018 & 2026
5.3. Topical
5.3.1. Market size and forecast, by region, 2018-2026
5.3.2. Comparative market share analysis, 2018 & 2026
6. Medical Marijuana Market, by Distribution Channel
6.1. Dispensaries
6.1.1. Market size and forecast, by region, 2018-2026
6.1.2. Comparative market share analysis, 2018 & 2026
6.2. Online
6.2.1. Market size and forecast, by region, 2018-2026
6.2.2. Comparative market share analysis, 2018 & 2026
7. Medical Marijuana Market, by Region
7.1. North America
7.1.1. Market size and forecast, by application, 2018-2026
7.1.2. Market size and forecast, by route of administration, 2018-2026
7.1.3. Market size and forecast, by distribution channel, 2018-2026
7.1.4. Market size and forecast, by country, 2018-2026
7.1.5. Comparative market share analysis, 2018 & 2026
7.1.6. U.S.
7.1.6.1. Market size and forecast, by application, 2018-2026
7.1.6.2. Market size and forecast, by route of administration, 2018-2026
7.1.6.3. Market size and forecast, by distribution channel, 2018-2026
7.1.6.4. Comparative market share analysis, 2018 & 2026
7.1.7. Canada
7.1.7.1. Market size and forecast, by application, 2018-2026
7.1.7.2. Market size and forecast, by route of administration, 2018-2026
7.1.7.3. Market size and forecast, by distribution channel, 2018-2026
7.1.7.4. Comparative market share analysis, 2018 & 2026
7.1.8. Mexico
7.1.8.1. Market size and forecast, by application, 2018-2026
7.1.8.2. Market size and forecast, by route of administration, 2018-2026
7.1.8.3. Market size and forecast, by distribution channel, 2018-2026
7.1.8.4. Comparative market share analysis, 2018 & 2026
7.2. Europe
7.2.1. Market size and forecast, by application, 2018-2026
7.2.2. Market size and forecast, by route of administration, 2018-2026
7.2.3. Market size and forecast, by distribution channel, 2018-2026
7.2.4. Market size and forecast, by country, 2018-2026
7.2.5. Comparative market share analysis, 2018 & 2026
7.2.6. Germany
7.2.6.1. Market size and forecast, by application, 2018-2026
7.2.6.2. Market size and forecast, by route of administration, 2018-2026
7.2.6.3. Market size and forecast, by distribution channel, 2018-2026
7.2.6.4. Comparative market share analysis, 2018 & 2026
7.2.7. Spain
7.2.7.1. Market size and forecast, by application, 2018-2026
7.2.7.2. Market size and forecast, by route of administration, 2018-2026
7.2.7.3. Market size and forecast, by distribution channel, 2018-2026
7.2.7.4. Comparative market share analysis, 2018 & 2026
7.2.8. France
7.2.8.1. Market size and forecast, by application, 2018-2026
7.2.8.2. Market size and forecast, by route of administration, 2018-2026
7.2.8.3. Market size and forecast, by distribution channel, 2018-2026
7.2.8.4. Comparative market share analysis, 2018 & 2026
7.2.9. Italy
7.2.9.1. Market size and forecast, by application, 2018-2026
7.2.9.2. Market size and forecast, by route of administration, 2018-2026
7.2.9.3. Market size and forecast, by distribution channel, 2018-2026
7.2.9.4. Comparative market share analysis, 2018 & 2026
7.2.10. UK
7.2.10.1. Market size and forecast, by application, 2018-2026
7.2.10.2. Market size and forecast, by route of administration, 2018-2026
7.2.10.3. Market size and forecast, by distribution channel, 2018-2026
7.2.10.4. Comparative market share analysis, 2018 & 2026
7.2.11. Netherland
7.2.11.1. Market size and forecast, by application, 2018-2026
7.2.11.2. Market size and forecast, by route of administration, 2018-2026
7.2.11.3. Market size and forecast, by distribution channel, 2018-2026
7.2.11.4. Comparative market share analysis, 2018 & 2026
7.2.12. Ireland
7.2.12.1. Market size and forecast, by application, 2018-2026
7.2.12.2. Market size and forecast, by route of administration, 2018-2026
7.2.12.3. Market size and forecast, by distribution channel, 2018-2026
7.2.12.4. Comparative market share analysis, 2018 & 2026
7.2.13. Denmark
7.2.13.1. Market size and forecast, by application, 2018-2026
7.2.13.2. Market size and forecast, by route of administration, 2018-2026
7.2.13.3. Market size and forecast, by distribution channel, 2018-2026
7.2.13.4. Comparative market share analysis, 2018 & 2026
7.3. Asia-Pacific
7.3.1. Market size and forecast, by application, 2018-2026
7.3.2. Market size and forecast, by route of administration, 2018-2026
7.3.3. Market size and forecast, by distribution channel, 2018-2026
7.3.4. Market size and forecast, by country, 2018-2026
7.3.5. Comparative market share analysis, 2018 & 2026
7.3.6. Australia
7.3.6.1. Market size and forecast, by application, 2018-2026
7.3.6.2. Market size and forecast, by route of administration, 2018-2026
7.3.6.3. Market size and forecast, by distribution channel, 2018-2026
7.3.6.4. Comparative market share analysis, 2018 & 2026
7.3.7. Israel
7.3.7.1. Market size and forecast, by application, 2018-2026
7.3.7.2. Market size and forecast, by route of administration, 2018-2026
7.3.7.3. Market size and forecast, by distribution channel, 2018-2026
7.3.7.4. Comparative market share analysis, 2018 & 2026
7.3.8. China
7.3.8.1. Market size and forecast, by application, 2018-2026
7.3.8.2. Market size and forecast, by route of administration, 2018-2026
7.3.8.3. Market size and forecast, by distribution channel, 2018-2026
7.3.8.4. Comparative market share analysis, 2018 & 2026
7.4. LAMEA
7.4.1. Market size and forecast, by application, 2018-2026
7.4.2. Market size and forecast, by route of administration, 2018-2026
7.4.3. Market size and forecast, by distribution channel, 2018-2026
7.4.4. Market size and forecast, by country, 2018-2026
7.4.5. Comparative market share analysis, 2018 & 2026
7.4.6. Brazil
7.4.6.1. Market size and forecast, by application, 2018-2026
7.4.6.2. Market size and forecast, by route of administration, 2018-2026
7.4.6.3. Market size and forecast, by distribution channel, 2018-2026
7.4.6.4. Comparative market share analysis, 2018 & 2026
7.4.7. Argentina
7.4.7.1. Market size and forecast, by application, 2018-2026
7.4.7.2. Market size and forecast, by route of administration, 2018-2026
7.4.7.3. Market size and forecast, by distribution channel, 2018-2026
7.4.7.4. Comparative market share analysis, 2018 & 2026
7.4.8. Chile
7.4.8.1. Market size and forecast, by application, 2018-2026
7.4.8.2. Market size and forecast, by route of administration, 2018-2026
7.4.8.3. Market size and forecast, by distribution channel, 2018-2026
7.4.8.4. Comparative market share analysis, 2018 & 2026
7.4.9. Columbia
7.4.9.1. Market size and forecast, by application, 2018-2026
7.4.9.2. Market size and forecast, by route of administration, 2018-2026
7.4.9.3. Market size and forecast, by distribution channel, 2018-2026
7.4.9.4. Comparative market share analysis, 2018 & 2026
8. Company profiles
8.1. mCig
8.1.1. Business overview
8.1.2. Financial performance
8.1.3. Product portfolio
8.1.4. Recent strategic moves & developments
8.1.5. SWOT analysis
8.2. Cannabis Sativa Inc.
8.2.1. Business overview
8.2.2. Financial performance
8.2.3. Product portfolio
8.2.4. Recent strategic moves & developments
8.2.5. SWOT analysis
8.3. ABcann Medicinals,Inc.
8.3.1. Business overview
8.3.2. Financial performance
8.3.3. Product portfolio
8.3.4. Recent strategic moves & developments
8.3.5. SWOT analysis
8.4. Aurora Cannabis, Inc.
8.4.1. Business overview
8.4.2. Financial performance
8.4.3. Product portfolio
8.4.4. Recent strategic moves & developments
8.4.5. SWOT analysis
8.5. Emerald Health Therapeutics
8.5.1. Business overview
8.5.2. Financial performance
8.5.3. Product portfolio
8.5.4. Recent strategic moves & developments
8.5.5. SWOT analysis
8.6. Insys Therapeutics, Inc.
8.6.1. Business overview
8.6.2. Financial performance
8.6.3. Product portfolio
8.6.4. Recent strategic moves & developments
8.6.5. SWOT analysis
8.7. Aphria, Inc.
8.7.1. Business overview
8.7.2. Financial performance
8.7.3. Product portfolio
8.7.4. Recent strategic moves & developments
8.7.5. SWOT analysis
8.8. Canopy Growth Corporation
8.8.1. Business overview
8.8.2. Financial performance
8.8.3. Product portfolio
8.8.4. Recent strategic moves & developments
8.8.5. SWOT analysis
8.9. GW Pharmaceuticals
8.9.1. Business overview
8.9.2. Financial performance
8.9.3. Product portfolio
8.9.4. Recent strategic moves & developments
8.9.5. SWOT analysis
8.10. Green Relief Inc.
8.10.1. Business overview
8.10.2. Financial performance
8.10.3. Product portfolio
8.10.4. Recent strategic moves & developments
8.10.5. SWOT analysis
Similar Reports
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
- Publish Date: February 26, 2018
- $5370
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
- Publish Date: May 29, 2018
- $5370
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...
- Publish Date: May 1, 2016
- $5370
